1QNZ

NMR structure of the 0.5b anti-HIV antibody complex with the gp120 V3 peptide

SOLUTION NMR

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	DRX	800
2	Bruker	DMX	600

NMR Refinement
Method	Details	Software
	THE STRUCTURE OF THE COMPLEX WAS DETERMINED ALLOWING THE ANTIBODY CDR RESIDUES AND THE COMPLEXED V3 PEPTIDE RESIDUES TO MOVE, WHILE THE ANTIBODY FRAMEWORK WAS HELD FIXED DURING REFINEMENT AND MODELED AS DESCRIBED PREVIOUSLY	X-PLOR

NMR Ensemble Information
Conformer Selection Criteria
Conformers Calculated Total Number
Conformers Submitted Total Number	1

Additional NMR Experimental Information
Details	THE STRUCTURE OF THE COMPLEX WAS DETERMINED BY ALLOWING THE CDRS OF THE 0.5B ANTIBODY AND THE V3 PEPTIDE RESIDUES TO MOVE WHILE THE FRAMEWORK OF THE ANTIBODY WAS MODELED AS DESCRIBED.

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	refinement	X-PLOR	3.8	BRUNGER
2	structure solution	NMRDRAW
3	structure solution	NMRVIEW
4	structure solution	XPLOR	3.8

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.